RARE DISEASERESEARCH ATLAS

ORPHA:93277

Monostotic fibrous dysplasia

high confidenceSubtype of disorder

Also known as: Jaffe-Lichtenstein disease

Publications

599

76.6th percentile

Trials

0

Interventional, condition-specific

Researchers

938

Distinct authors in sample

Gene link

Readiness

2/6

Stages with a signal

Orphanet entry

Cross-references

Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.

Additional Mondo synonyms (3)

monostotic fibrous dysplasia · monostotic fibrous dysplasia (disease) · monostotic fibrous dysplasia of bone

Research stages

Trial readiness signals

Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”

2/6 stages with a signal

No specific-condition interventional trial, but broader-category trials exist — discuss eligibility with a clinician.

  1. Gene identifiedNot found

    No GenCC disease–gene assertion in this build

  2. LiteraturePresent

    599 matched papers (177 in last 10 years) Source

  3. Phenotype characterisedNot checked

    Not yet enriched from Monarch / HPO

  4. Animal modelNot checked

    Not yet enriched from Monarch / Alliance

  5. Orphan designationNot checked

    FDA/EMA orphan-drug designation not enriched yet

  6. Interventional trialPartial

    None under the specific name; 16 for broader category fibrous dysplasia

Biology

Genes and phenotypes

Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.

Do we know what causes it?

Not yet — the cause hasn't been pinned down in GenCC.

No strong gene–disease assertion joined for this Orphanet entity.

Phenotypes (Monarch / HPO)

Not enriched in this build — Monarch phenotype joins were not run for this record.

Animal models (Monarch / Alliance)

Not enriched in this build.

Literature

Is anyone studying this?

599

599 papers have been published on this condition. That is a real research literature — still far smaller than common diseases (breast cancer: over 700,000 papers). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.

599 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).

177 in the last 10 years · high confidence · 76.6th percentile (publications denominator)

Phrase hits: 595 · MeSH hits: 7

Open Europe PMC search

Who's working on it?

938

Distinct author names in 200 sampled papers — named people below.

Who's working on it?

No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.

  1. 01
    Appelman-Dijkstra NM7 papers · 2025

    Department of Medicine, Division of Endocrinology, Leiden University Medical Center, Centre for Bone Quality, Leiden, The Netherlands.

    Papers in Europe PMC
  2. 02
    Yamamoto N4 papers · 2022

    Department of Orthopaedic Surgery, Kanazawa University Graduate School of Medical Sciences, 13-1 Takara-machi, Kanazawa, 920-8640, Ishikawa, Japan. norinori@med.kanazawa-u.ac.jp.

    Papers in Europe PMC
  3. 03
    Zhang C4 papers · 2025

    Department of Oral and Maxillofacial Head and Neck Surgery, Shanghai 9th People's Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai 200011, P.R. China.

    Papers in Europe PMC
  4. 04
    de Witte PB3 papers · 2025

    Department of Orthopaedics, Leiden University Medical Center, Leiden, The Netherlands.

    Papers in Europe PMC
  5. 05
    Hayashi K3 papers · 2022

    Department of Orthopaedic Surgery, Kanazawa University Graduate School of Medical Sciences, 13-1 Takara-machi, Kanazawa, 920-8640, Ishikawa, Japan.

    Papers in Europe PMC
  6. 06
    Miwa S3 papers · 2022

    Department of Orthopaedic Surgery, Kanazawa University Graduate School of Medical Sciences, 13-1 Takara-machi, Kanazawa, 920-8640, Ishikawa, Japan.

    Papers in Europe PMC
  7. 07
    Takeuchi A3 papers · 2022

    Department of Orthopaedic Surgery, Kanazawa University Graduate School of Medical Sciences, 13-1 Takara-machi, Kanazawa, 920-8640, Ishikawa, Japan.

    Papers in Europe PMC
  8. 08
    Tsuchiya H3 papers · 2022

    Department of Orthopaedic Surgery, Kanazawa University Graduate School of Medical Sciences, 13-1 Takara-machi, Kanazawa, 920-8640, Ishikawa, Japan.

    Papers in Europe PMC
  9. 09
    Abrahamsen B2 papers · 2024

    Department of Medicine, Holbæk Hospital, Denmark and OPEN, Institute of Clinical Research, University of Southern Denmark, Odense, Denmark.

    Papers in Europe PMC
  10. 10
    Agarwal N2 papers · 2014

    Department of Oral Medicine and Radiology, Kothiwal Dental College and Research Centre, Moradabad, Uttar Pradesh, India.

    Papers in Europe PMC

Clinical research

Is a treatment being tested?

0

interventional trials for this specific condition

No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present). 16 trials are registered for fibrous dysplasia, the broader category — shown separately because they may or may not enrol this specific subtype.

Data as of 27 July 2026

No matched interventional trials. This is true for 73% of diseases in the trials denominator (5114 of 7003). Here are the researchers publishing on it.

high confidence · 36.5th percentile (trials denominator)

Recruiting interventional trials

From the matched ClinicalTrials.gov set

No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.

16 interventional trials matched fibrous dysplasia, the broader category — listed below. Those studies are not counted in the condition-specific total.

Broader category: fibrous dysplasia

16

Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.

Worth raising with a clinician. How we count trials.

Recruiting under the broader category

Where to find support

We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:

India — NPRD

Last verified 2026-07-26

This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.

Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.

How we counted this

Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.

"Monostotic fibrous dysplasia" OR "Jaffe-Lichtenstein disease" OR "monostotic fibrous dysplasia (disease)" OR "monostotic fibrous dysplasia of bone" OR "monostotic fibrous dysplasia of the bone"

Run this search on Europe PMC

MeSH descriptor terms unioned into the query: Fibrous Dysplasia, Monostotic

ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):

"Monostotic fibrous dysplasia" OR "Jaffe-Lichtenstein disease" OR "monostotic fibrous dysplasia (disease)" OR "monostotic fibrous dysplasia of bone" OR "monostotic fibrous dysplasia of the bone" OR "Fibrous Dysplasia, Monostotic"

Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.

Parent-category trials query:

"fibrous dysplasia"

Query health: ok — strategies attempted: phrase, mesh; with hits: phrase, mesh

Run this search on ClinicalTrials.gov

Confidence reasoning

  • Preferred label is multi-word and distinctive
  • No synonyms dropped by stoplist
  • No label/synonym collisions with other diseases in this corpus

Ingested 2026-07-27T04:10:36.350Z